Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SSIC | US
-0.14
0.96%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
19/09/2024
11.60
11.34
11.72
11.34
Silver Spike Investment Corp. is a a business development company. It is a specialty finance company focuses on investing across the cannabis ecosystem through investments in the form of direct loans to and equity ownership of privately held cannabis companies. It intends to partner with private equity firms entrepreneurs business owners and management teams to provide credit and equity financing alternatives to support buyouts recapitalizations growth initiatives refinancings and acquisitions across cannabis companies including cannabis-enabling technology companies cannabis-related health and wellness companies and hemp and CBD distribution companies. The company was founded in 2021 and is based in New York New York.
View LessPositive Momentum
Strength based on increasing price with high volume
Low 6-Month Volatility (<30%)
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Strong Sharpe Ratio (> 1.2)
Microcap (<300M USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
18.5%1 month
13.9%3 months
22.8%6 months
23.0%12.64
-
0.84
-
-
-
6.52
-
-
72.09M
72.09M
8.79
66.81
6.70
6.50
6.41
3.05
0.59
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.88
Range1M
0.88
Range3M
1.32
Rel. volume
2.45
Price X volume
88.79K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.63 | 61.71M | 3.82% | n/a | 25.73% |
Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 4.27 | 55.33M | -0.23% | 5.07 | 27.85% |
Qilian International Holding Group Limited | QLI | Drug Manufacturers-Specialty & Generic | 8.08 | 48.23M | 1.00% | n/a | 1.35% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.37 | 42.52M | 1.48% | n/a | 318.92% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.0899 | 37.75M | 1.01% | n/a | 0.00% |
Cannex Capital Holdings Inc | ARRXF | Drug Manufacturers-Specialty & Generic | 0.1318 | 33.72M | n/a | 0.50% | |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3487 | 26.37M | 2.56% | n/a | 4.33% |
Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 4.77 | 25.51M | -4.79% | n/a | 0.00% |
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 3.14 | 20.92M | 3.29% | 0.77 | 22.86% |
Flora Growth Corp. Common Stock | FLGC | Drug Manufacturers-Specialty & Generic | 1.42 | 18.98M | 35.24% | n/a | 76.81% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 5.78 | 62.58M | -6.47% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.04 | 18.78M | 13.06% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 12.43M | -7.27% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.737 | 11.34M | 3.80% | n/a | 422.08% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6475 | 6.16M | -2.76% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.315 | 4.97M | -1.56% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.42 | 3.63M | 1.43% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.751 | 1.10M | 24.54% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 915.21K | -8.33% | n/a | -37.05% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.31 | 0 | 0.35% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 16.67 | - |
Ent. to Revenue | 6.52 | 309.37 | Cheaper |
PE Ratio | 12.64 | 29.14 | Cheaper |
Price to Book | 0.84 | 12.81 | Cheaper |
Dividend Yield | 8.79 | 2.80 | Leader |
Std. Deviation (3M) | 22.83 | 75.12 | Lower Risk |
Debt to Equity | - | -0.93 | - |
Debt to Assets | - | 0.45 | - |
Market Cap | 72.09M | 5.22B | Emerging |